A. Gaber

A. Gaber, R. Ghobrial, O. Barakat, 2009, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Polyomavirus in kidney and kidney‐‐pancreas transplant recipients

R. Stratta, A. Gaber, S. Vera, 2003, Transplant infectious disease : an official journal of the Transplantation Society.

Sustained improvement in cardiac function 24 months following pancreas-kidney transplant.

A. Gaber, D. Hathaway, B. Burlew, 1998, Transplantation proceedings.

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

A. Gaber, S. Busque, S. Mulgaonkar, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

THE EFFECT OF GUT METABOLISM ON TACROLIMUS BIOAVAILABILITY IN RENALTRANSPLANT RECIPIENTS1,2

Julie A. Johnson, A. Gaber, R. Alloway, 2001, Transplantation.

Outcomes of simultaneous kidney–pancreas transplantation in African‐American recipients: a case‐control study

R. Stratta, A. Gaber, H. Grewal, 2000, Clinical transplantation.

Timing of referral impacts surgical outcomes in patients undergoing repair of bile duct injuries.

A. Gaber, B. Fahy, R. Ghobrial, 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage.

R. Stratta, A. Gaber, H. Grewal, 2001, Transplantation proceedings.

Quality of Life Outcomes Associated with Variable Posttransplant Prednisone Dosing Regimens

A. Gaber, D. Hathaway, M. Wicks, 1996 .

Quality of life outcomes associated with variable posttransplant prednisone dosing regimens.

A. Gaber, D. Hathaway, M. Wicks, 1996, Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization.

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.

J. Vauthey, A. Gaber, E. Graviss, 2018, The lancet. Gastroenterology & hepatology.

Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation

Michael A. Yamin, A. Gaber, I. Goldberg, 2020, Transplantation.

The impact of pancreas transplantation on secondary complications of diabetes

A. Gaber, L. Moore, 2006 .

Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults

W. Suki, A. Gaber, O. Sabek, 2019, BMJ Open.

Development of a Web Site for Transplant Patient Education

A. Gaber, D. Hathaway, R. Winsett, 2001 .

Development of a Web site for transplant patient education.

A. Gaber, D. Hathaway, R. Winsett, 2001, Progress in transplantation.

Surgical Technique for Right Lobe Adult Living Donor Liver Transplantation Without Venovenous Bypass or Portocaval Shunting and With Duct-to-Duct Biliary Reconstruction

R. Stratta, A. Gaber, S. Vera, 2001, Annals of surgery.

Duct-to-duct biliary reconstruction in right lobe adult living donor liver transplantation.

R. Stratta, A. Gaber, S. Vera, 2001, Journal of the American College of Surgeons.

The Houston Methodist lung transplant risk model - a validated tool for pre-transplant risk assessment.

A. Gaber, T. Kaleekal, E. Graviss, 2019, The Annals of thoracic surgery.

Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients.

A. Gaber, E. Graviss, L. Teeter, 2021, Transplantation proceedings.

Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection.

A. Gaber, L. Gaber, A. Cashion, 2006, Transplantation proceedings.

Post kidney transplant quality of life prediction models.

A. Gaber, C. Johnson, D. Hathaway, 1998, Clinical transplantation.

Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.

A. Gaber, L. Gaber, J. Soulillou, 1998, Transplantation.

Initial survival data of kidney transplant patients with pre‐transplant monoclonal gammopathy

W. Suki, A. Gaber, Jiaqiong Xu, 2012, Clinical transplantation.

Routine early biopsy of allografts with delayed function: correlation of histopathology and transplant outcome.

A. Gaber, S. Vera, L. Gaber, 1996, Clinical transplantation.

Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era.

R. Stratta, A. Gaber, S. Vera, 2001, Surgery.

Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.

A. Gaber, T. A. Hughes, D. Hathaway, 1994, Metabolism: clinical and experimental.

Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.

A. Gaber, L. Gaber, T. Schroeder, 1999, Kidney international.

Stress conditioning: a novel approach to organ preservation.

A. Gaber, F. Stuart, G. Perdrizet, 1989, Current surgery.

Barriers to Preemptive Renal Transplantation: A Single Center Questionnaire Study

A. Gaber, E. Graviss, L. Teeter, 2015, Transplantation.

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.

K. Lamborn, R. Stratta, A. Gaber, 1998, Transplantation.

The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.

A. Gaber, L. Gaber, T. Schroeder, 1996, Transplantation.

Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation1

A. Gaber, M. Kotb, L. Gaber, 2002, Transplantation.

Reliability and Validity of Cardiovascular and Vasomotor Autonomic Function Tests

A. Gaber, D. Hathaway, S. Cardoso, 1994, Diabetes Care.

Kidney and pancreas transplantation

A. Gaber, V. Ashby, J. Pirsch, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double‐blind, randomized, placebo‐controlled trial

A. Gaber, E. Graviss, D. Nguyen, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The treatment of diabetes by transplantation

A. Gaber, 2002 .

IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection.

A. Gaber, X. Li, Guo-hua Wang, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Weight Gain After Simultaneous Kidney and Pancreas Transplantation

A. Gaber, E. Graviss, D. Nguyen, 2020, Transplantation.

Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study.

R. Stratta, A. Gaber, H. Grewal, 2001, Transplantation proceedings.

A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation.

R. Stratta, A. Gaber, H. Grewal, 1998, Surgery.

Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction.

R. Stratta, A. Gaber, H. Grewal, 1999, Annals of surgery.

The transplant center and business unit as a model for specialized care delivery.

A. Gaber, D. P. Bernard, R. Schwartz, 2013, The Surgical clinics of North America.

Risk Factors and Consequences of Delayed Graft Function in Deceased Donor Renal Transplant Patients Receiving Antithymocyte Globulin Induction

A. Gaber, L. Gaber, M. Egidi, 2008, Transplantation.

Association of dietary phosphate and serum phosphorus concentration by levels of kidney function.

W. Suki, A. Gaber, L. Moore, 2015, The American journal of clinical nutrition.

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma - Authors' reply.

J. Vauthey, A. Gaber, R. Ghobrial, 2018, The lancet. Gastroenterology & hepatology.

Assessment of human islet viability using various mouse models.

A. Gaber, O. Sabek, D. Fraga, 2005, Transplantation proceedings.

Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation

A. Gaber, D. Segev, D. Warren, 2022, Transplantation.

EARLY IMPROVEMENT IN CARDIAC FUNCTION OCCURS FOR PANCREAS‐KIDNEY BUT NOT DIABETIC KIDNEY‐ALONE TRANSPLANT RECIPIENTS

A. Gaber, R. Mccully, D. Hathaway, 1995, Transplantation.

Perceptions of the Donation Process from Adult-to-Adult Living Liver Donors

C. Russell, A. Gaber, H. Grewal, 2003 .

Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.

W. Suki, A. Gaber, R. Barrios, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration.

A. Gaber, E. Graviss, R. Ghobrial, 2021, Transplantation.

The role of mTOR inhibition in renal transplant immune suppression

A. Gaber, L. Gaber, A. Abdellatif, 2011 .

The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, Transplantation proceedings.

Evaluation of an immunosuppressant side effect instrument.

R. Stratta, A. Gaber, K. Arheart, 2004, Progress in transplantation.

Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients.

A. Gaber, E. Graviss, D. Nguyen, 2020, Transplantation proceedings.

Identification of the nature of hemostatic failure during transplantation of the liver.

A. Gaber, S. Vera, A. Zimmermann, 1989, Transplantation proceedings.

Impact of Long-Term Immunosuppressive Therapy on Psychosocial and Physical Well Being in Liver Transplant Recipients

A. Gaber, S. Vera, H. Grewal, 2003, Progress in transplantation.

Impact of long-term immunosuppressive therapy on psychosocial and physical well being in liver transplant recipients.

A. Gaber, S. Vera, H. Grewal, 2003, Progress in transplantation.

COMPARISON OF SIROLIMUS-BASED CALCINEURIN INHIBITOR-SPARING AND CALCINEURIN INHIBITOR-FREE REGIMENS IN CADAVERIC RENAL TRANSPLANTATION

A. Gaber, S. Vera, L. Gaber, 2004, Transplantation.

Antilymphocyte induction: effective immune suppression when the stakes are high?

A. Gaber, 2010, Transplantation proceedings.

Considerations in sirolimus use in the early and late post-transplant periods

A. Gaber, L. Gaber, R. Knight, 2009, Expert opinion on drug safety.

Observations on the use of cidofovir for BK virus infection in renal transplantation

A. Gaber, L. Gaber, R. Knight, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

IMPROVEMENT IN AUTONOMIC AND GASTRIC FUNCTION FOLLOWING PANCREAS‐KIDNEY VERSUS KIDNEY‐ALONE TRANSPLANTATION AND THE CORRELATION WITH QUALITY OF LIFE1,2

A. Gaber, T. Abell, D. Hathaway, 1994, Transplantation.

Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants.

A. Gaber, T. Abell, D. Hathaway, 1991, Digestive diseases.

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

W. Suki, A. Gaber, L. Gaber, 2012, Kidney international.

A comparison of media supplement methods for the extended culture of human islet tissue.

A. Gaber, D. Hathaway, O. Sabek, 1998, Transplantation.

PROSPECTIVE, RANDOMIZED TRIAL OF THE EFFECT OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION: THREE-YEAR RESULTS1

M. Stegall, A. Henning, A. Gaber, 2004, Transplantation.

Long‐term experience with simultaneous kidney–pancreas transplantation with portal‐enteric drainage and tacrolimus/mycophenolate mofetil‐based immunosuppression

R. Stratta, A. Gaber, H. Grewal, 2003, Clinical transplantation.

Improving results in solitary pancreas transplantation with portal‐enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil‐based immunosuppression

R. Stratta, A. Gaber, L. Gaber, 2003 .

Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression

R. Stratta, A. Gaber, L. Gaber, 2003, Transplant international : official journal of the European Society for Organ Transplantation.

Initial clinical experience with interleukin‐2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney‐pancreas transplantation

R. Stratta, A. Gaber, H. Grewal, 2001 .

Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation

R. Stratta, A. Gaber, H. Grewal, 2001, Transplant international : official journal of the European Society for Organ Transplantation.

Results of pancreas transplantation with portal venous and enteric drainage.

A. Gaber, A. Kitabchi, M. Saad, 1995, Annals of surgery.

Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.

Stephen T. C. Wong, Xiaobo Zhou, A. Gaber, 2010, Pharmacogenomics.

B-cell response in solid organ transplantation

A. Gaber, Wenhao Chen, S. Yi, 2022, Frontiers in Immunology.

Examination of gene expression profile of functional human pancreatic islets after 2-week culture.

A. Gaber, O. Sabek, D. Marshall, 2006, Transplantation proceedings.

Influence of human donor factors on pancreatic collagenase digestion.

A. Gaber, D. Hathaway, O. Sabek, 1998, Transplantation proceedings.

Simultaneous kidney-pancreas transplantation without antilymphocyte induction.

R. Stratta, A. Gaber, L. Gaber, 1998, Transplantation.

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.

A. Gaber, T. Pruett, S. Selman, 1998, Transplantation.

Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients.

A. Gaber, L. Gaber, M. Egidi, 2003, Transplantation proceedings.

RISK FACTORS FOR POSTIMPLANTATION PANCREATITIS AND PANCREATIC THROMBOSIS IN PANCREAS TRANSPLANT RECIPIENTS

A. Gaber, H. Grewal, L. Gaber, 1993, Transplantation.

Patterns of early weight change after renal transplantation

A. Gaber, L. Moore, 1996 .

EXERCISE RESULTS IN SUSTAINED IMPROVEMENT IN CARDIAC AUTONOMIC FUNCTION IN KIDNEY AND KIDNEY-PANCREAS TRANSPLANT RECIPIENTS

A. Gaber, R. Kreider, A. Cashion, 2001 .

Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage.

A. Gaber, M. Kotb, H. Grewal, 1994, Surgery.

Improvement in autonomic function following pancreas-kidney versus kidney-alone transplantation.

A. Gaber, T. Abell, L. Gaber, 1993, Transplantation proceedings.

An ideal nondiabetogenic, nonnephrotoxic immunosuppressive protocols for pancreas transplantation

A. Gaber, L. Gaber, M. Egidi, 2003 .

Conversion to sirolimus in solid organ transplantation: a single-center experience.

A. Gaber, M. Egidi, P. Cowan, 2003, Transplantation proceedings.

Prediction by postrevascularization biopsies of cadaveric kidney allografts of rejection, graft loss, and preservation nephropathy.

A. Gaber, L. Gaber, D. Hathaway, 1992, Transplantation.

Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.

A. Gaber, J. Thistlethwaite, F. Stuart, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Surgical complications after pancreas transplantation with portal-enteric drainage.

R. Stratta, A. Gaber, M. Egidi, 1999, Journal of the American College of Surgeons.

Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.

R. Stratta, A. Gaber, R. Alloway, 1998, Transplantation proceedings.

Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition.

A. Gaber, T. A. Hughes, D. Hathaway, 1995, Transplantation.

Changes in cardiac function of type I diabetics following pancreas-kidney and kidney-alone transplantation.

A. Gaber, D. Hathaway, B. Burlew, 1995, Transplantation proceedings.

Improved autonomic and gastric function in pancreas-kidney vs kidney-alone transplantation contributes to quality of life.

A. Gaber, T. Abell, D. Hathaway, 1994, Transplantation Proceedings.

Percutaneous biopsy of pancreas transplants.

A. Gaber, L. Gaber, D. Hathaway, 1992, Transplantation.

Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution

A. Gaber, R. Link, L. Stamatakis, 2013, BJU international.

Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience

R. Stratta, A. Gaber, H. Grewal, 2002, Clinical transplantation.

A 9-year experience with 126 pancreas transplants with portal enteric drainage.

R. Stratta, A. Gaber, H. Grewal, 2001, Archives of surgery.

The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.

A. Gaber, L. Gaber, M. First, 1999, Transplantation Proceedings.

A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference.

A. Gaber, L. Gaber, J. Soulillou, 1997, Transplantation proceedings.

Effect of Immunosuppression for First Kidney or Kidney/Pancreas Transplant on Sensitization at the Time of Second Transplant

A. Gaber, Jiaqiong Xu, R. Knight, 2011, Transplantation.

Correlation between Banff classification, acute renal rejection scores and reversal of rejection.

A. Gaber, L. Gaber, R. Alloway, 1996, Kidney international.

Short‐ and midterm results for internal jugular vein extension for short right renal vein kidney transplant

J. Bismuth, A. Gaber, C. Bechara, 2018, Clinical transplantation.

Changes in Weight during the First Year after Kidney Transplantation

A. Gaber, A. Cashion, D. Hathaway, 2007 .

Changes in weight during the first year after kidney transplantation.

A. Gaber, A. Cashion, D. Hathaway, 2007, Progress in transplantation.

Efficacy and cost‐effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high‐risk liver transplant recipients

A. Gaber, X. Li, R. Ghobrial, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Patterns of cytomegalovirus infection in simultaneous kidney–pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis

R. Stratta, A. Gaber, H. Grewal, 2001, Transplant infectious disease : an official journal of the Transplantation Society.

Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center

A. Gaber, M. Abdelrahim, R. Ghobrial, 2020, Transplantation.

Perceptions of the Donation Process from Adult-to-Adult Living Liver Donors

C. Russell, A. Gaber, H. Grewal, 2003, Progress in transplantation.

Evolving experience of hepatitis B virus prophylaxis in liver transplantation

R. Stratta, A. Gaber, S. Vera, 2002, Transplant infectious disease : an official journal of the Transplantation Society.

Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation

A. Gaber, S. Vera, C. Riely, 2003, Transplant infectious disease : an official journal of the Transplantation Society.

Detection of recurrent hepatitis B after OLT in patients treated with HBIG prophylaxis using graft-biopsy staining, anti-HBs titers and hepatitis B serology.

A. Gaber, S. Vera, M. Shokouh-amiri, 1997, Transplantation proceedings.

Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation.

A. Gaber, S. Vera, C. Riely, 1996, Clinical transplantation.

Three-month pegylated interferon-alpha-2 a therapy for chronic hepatitis E virus infection in a haemodialysis patient

W. Suki, A. Gaber, R. Barrios, 2010 .

Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody.

A. Gaber, L. Gaber, G. Land, 2013, Transplantation proceedings.

Pediatric renal transplant experience in Memphis, Tennessee.

A. Gaber, R. Wyatt, D. Batisky, 1994, Transplantation proceedings.

Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, The American surgeon.

Intermediate-Term Graft Loss After Renal Transplantation is Associated With Both Donor-Specific Antibody and Acute Rejection

A. Gaber, E. Graviss, G. Land, 2014, Transplantation.

EFFECT OF GUT METABOLISM ON TACROLIMUS (FK-506) BIOAVAILABILITY IN RENAL TRANSPLANT RECIPIENTS

Julie A. Johnson, A. Gaber, R. Alloway, 1999 .

Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone.

R. Stratta, A. Gaber, H. Grewal, 2001, Transplantation proceedings.

Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation

A. Gaber, C. V. van Buren, R. Kerman, 2010, Transplantation.

A technique for portal pancreatic transplantation with enteric drainage.

A. Gaber, H. Grewal, L. Britt, 1993, Surgery, gynecology & obstetrics.

The inflammatory cascade in acute pancreatitis: relevance to clinical disease.

A. Gaber, L. Gaber, O. Sabek, 2007, The Surgical clinics of North America.

Antithymocyte Globulin Induction in Living Donor Renal Transplant Recipients: Final Report of the TAILOR Registry

A. Gaber, S. Kapur, A. Matas, 2012, Transplantation.

A review of the evidence for use of thymoglobulin induction in renal transplantation.

A. Gaber, L. Gaber, R. Knight, 2010, Transplantation proceedings.

Diagnosis, management, and outcome of late duodenal complications in portal-enteric pancreas transplantation: case reports.

R. Stratta, A. Gaber, M. Shokouh-amiri, 1997, Journal of the American College of Surgeons.

Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.

A. Gaber, J. Soulillou, M. First, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Successful reuse of portal-enteric technique in pancreas retransplantation.

R. Stratta, A. Gaber, K. Reddy, 2000, Transplantation.

Pancreas transplantation with portal venous drainage and enteric exocrine diversion: a new technique.

A. Gaber, L. Gaber, L. Britt, 1992, Transplantation proceedings.

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients

W. Winkelmayer, K. Rezvani, A. Gaber, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pre-transplant T-cell Clonality

Stephen L. Jones, Stephen L Jones, A. Gaber, 2021, Annals of surgery.

Review of cyclosporine pharmacokinetic trials in healthy volunteers and kidney and liver transplant recipients: SangCyA versus neoral and sandimmune

A. Gaber, R. Fisher, W. Irish, 1999 .

Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database.

Stephen L. Jones, Stephen L Jones, A. Gaber, 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Liver transplantation in an adult with adenomatosis and congenital absence of the portal vein: a case report.

A. Gaber, R. Ghobrial, M. Schwartz, 2014, Transplantation proceedings.

T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, Transplantation proceedings.

Correlation of the outcome of renal transplantation with T cell flow cytometric immunofluorescence crossmatch results

A. Gaber, J. Thistlethwaite, M. Buckingham, 1986 .

The detrimental impact of persistent vs an isolated occurrence of de novo donor‐specific antibodies on intermediate‐term renal transplant outcomes

A. Gaber, E. Graviss, T. Eagar, 2017, Clinical transplantation.

The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients

A. Gaber, M. Kotb, L. Gaber, 1999, Clinical transplantation.

Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, Transplantation proceedings.

Human granulocytic ehrlichiosis in pancreas transplant recipients

R. Stratta, A. Gaber, M. Egidi, 2001, Transplant infectious disease : an official journal of the Transplantation Society.

Clinical implications of flow cytometry B cell crossmatching in renal transplantation.

A. Gaber, M. Kotb, D. Hathaway, 1997, Transplantation proceedings.

Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm.

A. Gaber, R. Ghobrial, S. Gordon-Burroughs, 2017, Transplantation proceedings.

Serial analysis of biomarkers of acute pancreas allograft rejection

A. Gaber, L. Gaber, A. Cashion, 2010, Clinical transplantation.

Belatacept conversion in an HIV‐positive kidney transplant recipient following anti‐thymocyte globulin induction

A. Gaber, R. Crutchley, R. Knight, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection.

A. Gaber, M. Kotb, H. Grewal, 1993, Transplantation proceedings.

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

Jenny C. Chang, A. Gaber, M. Abdelrahim, 2022, Cancers.

Observations on recovery of renal function following treatment for acute rejection.

A. Gaber, T. Schroeder, L. Moore, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

New‐Onset Diabetes After Transplantation: Results From a Double‐Blind Early Corticosteroid Withdrawal Trial

A. Henning, A. Gaber, J. Pirsch, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Improvement in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts.

A. Gaber, D. Hathaway, D. Elmer, 1994, Transplantation proceedings.

Evaluation of an Immunosuppressant Side Effect Instrument

R. Stratta, A. Gaber, K. Arheart, 2004 .

Successful reversal of hyperacute renal allograft rejection with the anti-CD3 monoclonal OKT3.

A. Gaber, S. Vera, L. Gaber, 1992, Transplantation.

Simultaneous Scalp, Skull, Kidney, and Pancreas Transplant from a Single Donor

M. Hanasono, P. Yu, R. Skoracki, 2016, Plastic and reconstructive surgery.

Use of FK506 immunosuppressive therapy in pancreas transplantation.

A. Gaber, R. Alloway, D. Hathaway, 1996, Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization.

Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction.

R. Stratta, A. Gaber, H. Grewal, 2002, Transplantation proceedings.

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients

A. Gaber, B. Kaplan, R. Alloway, 2013, Transplantation.

Treatment of Acute Tacrolimus Toxicity with Phenytoin in Solid Organ Transplant Recipients

W. Suki, A. Gaber, A. Bhimaraj, 2013, Case reports in transplantation.

A Limited Sampling Strategy for the Estimation of 12‐Hour SangCya and Neoral AUCs in Renal Transplant Recipients

A. Gaber, H. Meier‐Kriesche, B. Kaplan, 1999, Journal of clinical pharmacology.

The relationship of glucose disappearance rate (kG) to acute pancreas allograft rejection.

A. Gaber, D. Hathaway, H. Shokouh-Amiri, 1994, Transplantation.

GLOMERULOSCLEROSIS AS A DETERMINANT OF POSTTRANSPLANT FUNCTION OF OLDER DONOR RENAL ALLOGRAFTS

A. Gaber, S. Vera, L. Gaber, 1995, Transplantation.

Ipsilateral placement in double-kidney transplantation.

A. Gaber, R. Mehrazin, L. Gaber, 2007, Transplantation.

Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique

A. Gaber, E. Graviss, L. Teeter, 2016, Journal of transplantation.

Author's Reply: Ipsilateral Double Kidney Transplantation

A. Gaber, 2008 .

Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients.

A. Gaber, D. Hathaway, B. Burlew, 1995 .

Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.

R. Stratta, A. Gaber, D. Hathaway, 1998, Transplantation proceedings.

Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage.

R. Stratta, A. Gaber, H. Grewal, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of surveillance biopsies in monitoring recipients of pancreas alone transplants.

R. Stratta, A. Gaber, H. Grewal, 2001, Transplantation proceedings.

Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients

W. Suki, A. Gaber, A. Abdellatif, 2013 .

Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant.

A. Gaber, A. Cashion, D. Hathaway, 1999, Transplantation.

Autonomic cardiac dysfunction in diabetic transplant recipients succumbing to sudden cardiac death.

A. Gaber, D. Hathaway, D. Elmer, 1995, Transplantation.

Pancreas transplantation with portal venous and enteric drainage eliminates hyperinsulinemia and reduces postoperative complications.

A. Gaber, A. Kitabchi, L. Gaber, 1993, Transplantation proceedings.

Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts.

A. Gaber, L. Gaber, D. Hathaway, 1998, Clinical transplantation.

Posttransplant improvement in heart rate variability correlates with improved quality of life.

A. Gaber, A. Cashion, D. Hathaway, 1998, Western journal of nursing research.

Bortezomib in Kidney Transplantation

A. Gaber, R. Raghavan, A. Abdellatif, 2010, Journal of transplantation.

Effects of Pancreas Transplantation on Secondary Complications of Diabetes

A. Gaber, D. Kaufman, W. Kennedy, 2004 .

Identification of quality-of-life outcomes distinguishing diabetic kidney-alone and pancreas-kidney recipients.

A. Gaber, D. Hathaway, D. Crom, 1995, Transplantation proceedings.

Randomized double-blind study of standard versus low-dose OKT3 induction therapy in renal allograft recipients

A. Gaber, S. Vera, L. Gaber, 1993, Pediatric Nephrology.

Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience

A. Gaber, H. Seethamraju, L. Moore, 2012, Clinical transplantation.

Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study

A. Gaber, P. McCullough, E. Erhardtsen, 2017, BMJ Open.

Lifestyle behaviors affect cardiovascular risk status in men 1 year after kidney transplantation

A. Gaber, M. Egidi, D. Hathaway, 2001, Clinical transplantation.

Clinical Utility of Histological Features of Polyomavirus Allograft Nephropathy

R. Stratta, A. Gaber, L. Gaber, 2006, Transplantation.

Acute Rejection Characteristics From a Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Early Corticosteroid Withdrawal

A. Henning, A. Gaber, E. Woodle, 2013, Transplantation.

Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole.

A. Gaber, S. Vera, R. Alloway, 1996, Transplantation.

Combined lung and liver transplantation: Analysis of a single‐center experience

M. Loebe, A. Gaber, R. Ghobrial, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Rhodococcus equi pulmonary infection in a pancreas‐alone transplant recipient: consequence of intense immunosuppression

R. Stratta, A. Gaber, H. Grewal, 2002, Transplant infectious disease : an official journal of the Transplantation Society.

Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.

R. Stratta, A. Gaber, H. Grewal, 2001, Transplantation Proceedings.

Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience

A. Gaber, E. Graviss, R. Ghobrial, 2020, Transplantation.

Comparison of Sirolimus Plus Tacrolimus Versus Sirolimus Plus Cyclosporine in High-Risk Renal Allograft Recipients: Results From an Open-Label, Randomized Trial

A. Gaber, C. V. van Buren, B. Kahan, 2008, Transplantation.

Changes in abdominal wounds following treatment with sirolimus and steroids in a rat model.

A. Gaber, M. Gaber, L. Gaber, 2006, Transplantation proceedings.

Autonomic dysregulation in patients awaiting kidney transplantation.

A. Gaber, A. Cashion, D. Hathaway, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Letter to the editor [1]

A. Gaber, A. Olyaei, M. First, 1999 .

Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1.

W. Suki, A. Gaber, L. Moore, 2019, Kidney international.

Development of an index to predict posttransplant diabetes mellitus.

A. Gaber, D. Hathaway, M. Blakely, 1993, Clinical transplantation.

Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids.

A. Gaber, M. Egidi, 2003, Transplantation.

A PROSPECTIVE COMPARISON OF SYSTEMIC-ENTERIC VERSUS PORTAL-ENTERIC DRAINAGE AFTER SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION

R. Stratta, A. Gaber, H. Grewal, 1999 .

The Effect of Adrenal Replacement Therapy on Rates of Fungal Colonization and Mortality in Critically Ill Patients Awaiting Liver Transplantation

Stephen L. Jones, Stephen L Jones, A. Gaber, 2013, Journal of clinical and translational hepatology.

OKT3 TREATMENT OF STEROID‐RESISTANT RENAL ALLOGRAFT REJECTION

A. Gaber, J. Thistlethwaite, C. Broelsch, 1987, Transplantation.

Factors affecting survival after liver retransplantation: a systematic review and meta-analysis

Y. Cheah, A. Gaber, R. Ghobrial, 2023, Frontiers in Transplantation.

Liver Transplant for Hepatocellular Carcinoma

A. Gaber, R. Ghobrial, T. Aloia, 2011 .

Screening for BK Viremia Reduces But Does Not Eliminate the Risk of BK Nephropathy: A Single-Center Retrospective Analysis

A. Gaber, L. Gaber, L. Moore, 2013, Transplantation.

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy.

A. Gaber, L. Gaber, L. Moore, 2013, Transplantation.

FUNCTIONAL CAPACITY AND CARDIOVASCULAR RISK FACTORS IN KIDNEY AND KIDNEY-PANCREAS TRANSPLANT RECIPIENTS

A. Gaber, R. Kreider, A. Cashion, 2002 .

Successful Kidney Transplantation Is Associated With Weight Gain From Truncal Obesity and Insulin Resistance.

W. Mitch, A. Gaber, B. Workeneh, 2019, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Sustained Improvements in Cardiac Geometry and Function following Kidney–Pancreas Transplantation

A. Gaber, D. Hathaway, B. Burlew, 2000, Cell transplantation.

Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis.

R. Stratta, A. Gaber, H. Grewal, 1998, Clinical transplants.

Stakeholders' Perspectives on Transplant Metrics: The 2022 Scientific Registry of Transplant Recipients' Consensus Conference.

A. Israni, B. Kasiske, A. Gaber, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report

A. Gaber, Hina Faisal, A. Bloom, 2020, A&A practice.

The Association of Pretransplant Pulmonary Hypertension With Patient and Graft Survival After Kidney Transplantation: A Retrospective Cohort Study.

W. Suki, A. Gaber, A. Frost, 2020, Transplantation proceedings.

Bortezomib in kidney transplant desensitization: a case report.

W. Suki, A. Gaber, G. Land, 2009, Clinical transplants.

Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients.

A. Gaber, L. Moore, S. Acchiardo, 1994, Clinical transplantation.

Psychiatric complications after liver transplantation.

A. Gaber, S. Vera, H. Grewal, 2001, Transplantation proceedings.

Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood.

A. Gaber, S. Vera, T. Lobe, 1992, Journal of pediatric surgery.

Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation?

A. Gaber, M. Egidi, A. Lo, 2005, Transplantation Proceedings.

Effectiveness of Bariatric Surgery in Increasing Kidney Transplant Eligibility in Patients with Kidney Failure Requiring Dialysis

A. Gaber, B. Kash, V. Sherman, 2021, Obesity Surgery.

Cross-sectional and Case-Control Analyses of the Association of Kidney Function Staging With Adverse Postoperative Outcomes in General and Vascular Surgery

Stephen L Jones, W. Suki, A. Gaber, 2013, Annals of surgery.

Stabilization of bone mass after renal transplant with preemptive care.

A. Gaber, T. Hughes, R. Alloway, 1998, Transplantation Proceedings.

The echocardiographic course of pretransplant pulmonary hypertension following kidney transplantation and associated outcomes

W. Suki, A. Gaber, A. Frost, 2021, Pulmonary circulation.

Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti‐thymocyte globulin vs basiliximab

A. Gaber, E. Graviss, D. Nguyen, 2020, Transplant Infectious Disease.

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.

A. Gaber, E. Graviss, D. Nguyen, 2016, Clinical transplants.

An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation.

A. Gaber, L. Gaber, D. Hathaway, 1995, Transplantation.

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement

M. Stegall, A. Gaber, K. Romero, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A limited sampling strategy to predict the Sang-35 area under the curve in adult renal transplant recipients

A. Gaber, B. Kaplan, R. Alloway, 1998 .

Pre‐transplant utilization of sorafenib is not associated with increased complications after liver transplantation

A. Gaber, R. Ghobrial, H. Monsour, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Ten years of chronic immunosuppressive therapy following orthotopic liver transplantation: impact on health and quality of life.

R. Stratta, A. Gaber, S. Vera, 2001, Transplantation proceedings.

Use of amphotericin B to clear fungal contamination of islet tissue isolated from contaminated source pancreas.

A. Gaber, D. Hathaway, O. Sabek, 1995, Transplantation Proceedings.

Evaluation of Carotid Ultrasonography Screening Among Kidney Transplant Candidates: A Single-Center, Retrospective Study

W. Suki, A. Gaber, J. Swan, 2017, Transplantation direct.

Monitoring of pancreas allograft function with glucose disappearance rate (k(G)): Calculation and interpretation

A. Gaber, D. Hathaway, D. Elmer, 1994 .